| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 11.888 | 19.863 | 14.191 | 20.866 | 20.453 | 23.987 | 28.938 |
| Total Income - EUR | - | - | - | 11.888 | 19.863 | 14.191 | 21.582 | 20.989 | 24.364 | 29.212 |
| Total Expenses - EUR | - | - | - | 1.928 | 7.188 | 7.060 | 8.091 | 12.507 | 11.146 | 20.779 |
| Gross Profit/Loss - EUR | - | - | - | 9.960 | 12.675 | 7.131 | 13.491 | 8.483 | 13.218 | 8.434 |
| Net Profit/Loss - EUR | - | - | - | 9.603 | 12.079 | 6.733 | 13.002 | 7.881 | 11.416 | 6.779 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Euderm S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 763 | 340 | 15.311 | 11.220 | 9.525 | 6.518 |
| Current Assets | - | - | - | 9.748 | 13.381 | 7.179 | 3.615 | 7.307 | 6.972 | 16.638 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 0 | 1.043 | 0 | 0 | 6.580 | 0 | 1.297 |
| Cash | - | - | - | 9.748 | 12.338 | 7.179 | 3.615 | 727 | 6.972 | 15.341 |
| Shareholders Funds | - | - | - | 9.646 | 12.130 | 6.783 | 13.051 | 7.930 | 12.762 | 19.470 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 102 | 2.014 | 736 | 5.224 | 9.886 | 3.391 | 3.586 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 1.241 | 710 | 344 | 101 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Euderm S.r.l.